376-390 of 931
Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Project Oncology®Redefining Risk in Endometrial Cancer: Recurrence Prediction with Machine Learning
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Project Oncology®Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
On the Frontlines of Prostate CancerEvolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Daniel J. George, MD
ADT Monotherapy for mHSPC: How to Identify the Right Patients
On the Frontlines of Prostate CancerADT Monotherapy for mHSPC: How to Identify the Right Patients
Daniel J. George, MD
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
On the Frontlines of Prostate CancerRedefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Daniel J. George, MD
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerAdvancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Megan Kruse, MD
- advertisement
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerOptimizing Quality of Life in HER2+ Metastatic Breast Cancer
Megan Kruse, MD
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Living RheumRecognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Laura Cappelli, MD, MHS,MS
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Project Oncology®Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's RoundtableProstate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Ihtisham Ahmad
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerBalancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Paolo Tarantino, MD
- advertisement
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
On the Frontlines of Metastatic Breast CancerNavigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Paolo Tarantino, MD
Reducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
On the Frontlines of Prostate CancerReducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
Mohit Khera, M.D., M.B.A., M.P.H.
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Project Oncology®Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab